Digene fires Abbott to go with Roche in Europe
This article was originally published in Clinica
Digene has terminated its marketing and distribution agreement with Abbott Laboratories for Digenes's human papllomavirus (HPV) test. At the same time, it is downgrading its agreement with Abbott for distribution of Digene's hepatitis B DNA tests to a non-exclusive agreement for the remainder of its term. The move cleared the way for Digene to sign a deal with Abbott's competitor, Roche, which it announced on the same day last week.
You may also be interested in...
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.